# SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
> **ANDA205981** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2023-07-31
## Drug
- **FDA Application Number:** ANDA205981
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
- **Generic name:** SAXAGLIPTIN AND METFORMIN
- **Active ingredients:** METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MYLAN
- **Manufacturer:** Mylan Pharmaceuticals Inc.
- **First approval:** 2023-07-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205981)
---
*AI Analytics · CC0 1.0*